Behandling med Volibris resulterede i en stigning i middel hjerteindeks, et fald i middel lungearterietryk og et fald i middel pulmonal vaskulær resistens.
Treatment with Volibris resulted in an increase in mean cardiac index, a decrease in mean pulmonary artery pressure, and a decrease in mean pulmonary vascular resistance.